title: [A case of a septic pulmonary embolism-related implanted central venous port].
abstract: We report a case of a 32-year-old woman with a septic pulmonary embolism-related implanted central venous port. She was treated with S-1/cisplatin(CDDP)chemotherapy for recurrent gastric cancer. Her disease was progressive after five courses of S-1/CDDP combination therapy. Because of peritonitis carcinomatosa, her oral intake was poor, so we placed an implanted central venous port in her right subclavian vein. We administered 5-FU/Leucovorin/paclitaxel combination therapy and total parenteral nutrition from the port. Chemotherapy was effective, so we stopped total parenteral nutrition after one month. Two months later, multiple nodular shadows appeared in her left lung fields without apparent symptoms. Because we suspected septic pulmonary embolism related to the venous port, we removed the venous port promptly and administered antibiotics with a broad spectrum. Pulmonary shadows disappeared immediately, and no recurrence was observed afterward.
authors.affiliation: Dept. of Clinical Oncology, Osaka City General Hospital, Japan.
authors.forename: Hideaki
authors.initials: H
authors.lastname: Okada
authors.forename: Koichi
authors.initials: K
authors.lastname: Taira
authors.forename: Shinya
authors.initials: S
authors.lastname: Tokunaga
authors.forename: Haruko
authors.initials: H
authors.lastname: Daga
authors.forename: Manabu
authors.initials: M
authors.lastname: Tsuda
authors.forename: Natsuko
authors.initials: N
authors.lastname: Miyamoto
authors.forename: Masayoshi
authors.initials: M
authors.lastname: Nishijima
authors.forename: Mitsuhiro
authors.initials: M
authors.lastname: Sumitani
authors.forename: Seiichi
authors.initials: S
authors.lastname: Syoji
authors.forename: Koji
authors.initials: K
authors.lastname: Takeda
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002405:Catheterization, Central Venous / Q000009:adverse effects; D002408:Catheters, Indwelling / Q000009:adverse effects; D002945:Cisplatin / Q000008:administration & dosage; D004338:Drug Combinations; D005260:Female; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy / Q000601:surgery; D010094:Oxonic Acid / Q000008:administration & dosage; D011655:Pulmonary Embolism / Q000209:etiology*; D018805:Sepsis / Q000150:complications* / Q000188:drug therapy; D013274:Stomach Neoplasms / Q000188:drug therapy / Q000601:surgery; D005641:Tegafur / Q000008:administration & dosage
chemical_list: D004338:Drug Combinations; C079198:S 1 (combination); D005641:Tegafur; D010094:Oxonic Acid; D002945:Cisplatin